No Data
No Data
Longevity Medical Institute Integrates OncoSeek to Launch One of Mexico's Most Advanced Cancer Screening Programs
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Cramer's Lighting Round: 'I Would Be a Buyer' of Grail
GRAIL Is Maintained at Equal-Weight by Morgan Stanley
GRAIL Analyst Ratings
Express News | Grail Inc : Morgan Stanley Raises Target Price to $20.00 From $16.00